The importance of doxorubicin and methotrexate dose intensity in the chemotherapy of osteosarcoma

A. Kawai, S. Sugihara, T. Kunisada, M. Hamada, H. Inoue

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Abstract

The relationship between dose intensity of cytotoxic agents and therapeutic results was examined in a retrospective analysis of 32 patients with non-metastatic high-grade osteosarcoma of the extremities. The average dose intensities of individual agents were 9.8 mg/m2/week for doxorubicin, 1.2 g/m2/week for methotrexate, and 10.5 mg/m2/week for cisplatinum. The dose intensities of doxorubicin and methotrexate were significantly correlated with the clinical results, while that of cisplatinum was not. These results indicate that maximal dose intensification of doxorubicin and methotrexate is an important determinant of treatment outcome for patients with osteosarcoma.

Original languageEnglish
Pages (from-to)68-70
Number of pages3
JournalArchives of Orthopaedic and Trauma Surgery
Volume115
Issue number2
DOIs
Publication statusPublished - Mar 1 1996

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Fingerprint Dive into the research topics of 'The importance of doxorubicin and methotrexate dose intensity in the chemotherapy of osteosarcoma'. Together they form a unique fingerprint.

Cite this